Inclusion Criteria:~* Age 60 - 85 (inclusive)~* Willing and able to provide informed consent~* Clinical
presentation consistent with MCI due to AD or of mild AD~ * Gradual progressive decline in memory function over
>6 months~ * Amnestic presentation on neuropsychological testing with rapid forgetting (% reduction 1.5
standard deviations below the mean)~ * Clinical Dementia Rating (CDR) Sum of Box (SOB) score â‰¥0.5~ *
Mini-Mental State Examination (MMSE) range: 20 to 30~* Brain hypometabolism by 18F-2-fluoro-2-deoxyglucose
(FDG)-PET~* Participants may be taking medications for AD, provided that the dose of these medications has been
stable for >3 months.~
